These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18766960)

  • 21. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.
    Barbouti A; Johansson B; Höglund M; Mauritzson N; Strömbeck B; Nilsson PG; Tanke HJ; Hagemeijer A; Mitelman F; Fioretos T
    Genes Chromosomes Cancer; 2002 Oct; 35(2):127-37. PubMed ID: 12203776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant BCR-ABL transcript with intronic insertion in a patient with philadelphia chromosome-positive chronic myeloid leukemia: implications for disease progression.
    Shiratsuchi M; Muta K; Minami R; Motomura S; Suehiro Y; Abe Y; Shiokawa S; Umemura T; Fukui T; Nishimura J; Nawata H
    Leuk Lymphoma; 2001 Apr; 41(3-4):411-5. PubMed ID: 11378554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
    Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
    Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
    Andrews DF; Collins SJ
    Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
    Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
    Peng C; Li S
    Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of transformation by the BCR-ABL oncogene.
    Sattler M; Griffin JD
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):4-10. PubMed ID: 12783368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A causal Bayesian network model of disease progression mechanisms in chronic myeloid leukemia.
    Koch D; Eisinger RS; Gebharter A
    J Theor Biol; 2017 Nov; 433():94-105. PubMed ID: 28870619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cytogenetic scenario of chronic myeloid leukemia.
    Mitelman F
    Leuk Lymphoma; 1993; 11 Suppl 1():11-5. PubMed ID: 8251885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myelogenous leukemia: mechanisms underlying disease progression.
    Shet AS; Jahagirdar BN; Verfaillie CM
    Leukemia; 2002 Aug; 16(8):1402-11. PubMed ID: 12145676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic myeloid leukemia in 2007.
    Sessions J
    Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S4-9. PubMed ID: 18056931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
    Luatti S; Baldazzi C; Marzocchi G; Ameli G; Bochicchio MT; Soverini S; Castagnetti F; Tiribelli M; Gugliotta G; Martinelli G; Baccarani M; Cavo M; Rosti G; Testoni N
    Oncotarget; 2017 May; 8(18):29906-29913. PubMed ID: 28404889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
    Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.